Response of OPMEDIC GROUP Inc. to the Press Release and Inquiry Report of the Régie de l'assurance maladie du Québec (RAMQ) Published on June 5, 2007 Regarding the Billing of Ancillary Costs


(TSX: "OMG"), a healthcare-related service company providing facilities and
services to patients and surgeons, wishes to confirm that its Opmedic division
will comply with the inquiry's findings.
    Consequently, Opmedic Laval will continue to mainly offer uninsured
cosmetic surgical procedures where patients defray total costs for the fees
and professional expenses involved. For all surgeries covered by the Quebec
health insurance program and performed by physicians participating in the
program, from now on, Opmedic will only charge patients for anesthetics and
medicines in accordance with Article 2.1 of the Préambule général de l'Entente
de la Loi de l'Assurance Maladie du Québec. Opmedic Group points out that the
professional fees of participating physicians performing the surgical
procedures covered by the program are only paid by the RAMQ. The surgeons
working in these facilities do not receive any further compensation from
either the patients or Opmedic Group Inc.
    Opmedic Group wishes from the Ministère de la Santé et des Services
sociaux (the "Ministry of Health") a prompt clarification of the terms and
conditions of the program pertaining to the ancillary costs that can be
charged to patients for elective one day surgeries covered by the Quebec
health insurance program.
    Furthermore, Opmedic Group hopes that in its review, the Ministry of
Health takes into account the inherent costs of such surgeries incurred by the
clinics by setting up terms and conditions for the ancillary costs that may be
billed to patients.
    Opmedic's first objective remains to provide an affordable alternative to
patients awaiting elective day surgery.


    OPMEDIC GROUP is a company incorporated under the laws of the Province of
Quebec which provides healthcare-related services including surgical
facilities and services to patients and surgeons (with its OPMEDIC division),
fertility treatments, medical imaging, laboratory services and diagnostic
procedures (with its PROCREA Cliniques division) and sperm banking services
(with its PROCREA Cryopreservation Centre subsidiary). OPMEDIC GROUP's Common
Shares trade on the Toronto Stock Exchange under the symbol "OMG".

    This news release does not constitute an offer to sell or to solicitation
of an offer to buy any security and shall not constitute an offer,
solicitation or sale in any jurisdiction in which such offering would be
unlawful. This news release contains certain forward-looking statements that
reflect the current views and/or expectations of OPMEDIC GROUP with respect to
its performance, business and future events. Such statements are subject to a
number of risks, uncertainties and assumptions. Actual results and events may
vary significantly.

    The Content of this press release has not been approved by nor submitted
    to the TSX which assumes no liability therefore.

For further information:

For further information: Paulo BOUCA, Vice President Business
Development and Chief Operating Officer, (514) 345-8535, x 2254,; Dr. Josée PROVENCHER, Medical Director, OPMEDIC
Laval, (450) 662-9393

Organization Profile

Opmedic Group Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890